ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 142 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,179,000 | +607.1% | 221,597 | +341.8% | 0.00% | – |
| Q2 2019 | $591,000 | -64.5% | 50,155 | -58.8% | 0.00% | -100.0% |
| Q1 2019 | $1,664,000 | +59.5% | 121,837 | +19.6% | 0.00% | – |
| Q4 2018 | $1,043,000 | +207.7% | 101,832 | +399.8% | 0.00% | – |
| Q3 2018 | $339,000 | +591.8% | 20,376 | +559.8% | 0.00% | – |
| Q2 2018 | $49,000 | -98.3% | 3,088 | -98.7% | 0.00% | -100.0% |
| Q1 2018 | $2,906,000 | +1437.6% | 228,837 | +1284.0% | 0.00% | – |
| Q4 2017 | $189,000 | -80.0% | 16,534 | -78.5% | 0.00% | – |
| Q3 2017 | $943,000 | +7758.3% | 77,010 | +7547.5% | 0.00% | – |
| Q2 2017 | $12,000 | -63.6% | 1,007 | -37.7% | 0.00% | – |
| Q1 2017 | $33,000 | -95.7% | 1,617 | -95.7% | 0.00% | – |
| Q4 2016 | $776,000 | +2671.4% | 37,313 | +4269.2% | 0.00% | – |
| Q3 2016 | $28,000 | -31.7% | 854 | -47.8% | 0.00% | – |
| Q2 2016 | $41,000 | -84.9% | 1,636 | -85.3% | 0.00% | – |
| Q1 2016 | $272,000 | -65.6% | 11,129 | -53.5% | 0.00% | -100.0% |
| Q4 2015 | $791,000 | -79.0% | 23,932 | -79.2% | 0.00% | -66.7% |
| Q3 2015 | $3,773,000 | -47.5% | 115,181 | -15.1% | 0.00% | -40.0% |
| Q2 2015 | $7,183,000 | – | 135,603 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |